The COVID-19 pandemic is having a significant impact on various markets globally. Because it is an unprecedented situation that is evolving at a rapid pace, DRG (part of Clarivate) continues to closely monitor ongoing events as the situation progresses.
The market impact assessments below provide a broad summary of potential impact on key factors like company sales/revenue, procedure volumes, pricing, product launches, clinical trials, and supply chain. Relevant guidance and recommendations are also outlined.
The analysis is based on currently available information, and more updates will be provided as we learn more over the coming weeks and months.